Sign In

Robert Pelzer

Director at Sierra Oncology

Robert E. Pelzer is an accomplished pharmaceutical executive with extensive international experience. He served as a Board Member at Sierra Oncology from 2015 to July 2022.3 In November 2019, he was appointed as the Chairman of the Board of Directors at Sierra Oncology following the company's $103 million public offering.1

Pelzer's career highlights include:

  1. President of Novartis Corporation and Head of Legal Affairs2
  2. Global General Counsel and Head of Legal Services at Novartis Pharma AG in Basel, Switzerland2
  3. General Counsel and Senior Vice President at DuPont Pharmaceuticals2
  4. Various positions at DuPont, including Director and General Manager for the European oil and gas business2

He holds degrees in Commerce and Law from the University of Alberta and has been admitted as a Barrister and Solicitor in Alberta, Canada, and as a Solicitor in England and Wales.2

Currently, Pelzer serves as a Director at Qu Biologics, where he is on the Finance and Audit Committee and the Compensation Committee.2 His extensive pharmaceutical executive experience, including both legal and operational roles, has been valuable to the companies he has served.2

Highlights

Sep 16 · qubiologics.com
Robert E. Pelzer, LLB - Qu Biologics
Nov 26 · bctechnology.com
Vancouver-based Sierra Oncology Announces Closing of $103 ...

Related Questions

What are Robert Pelzer's main responsibilities as Chairman of the Board at Sierra Oncology?
How has Robert Pelzer's career evolved since joining Abingworth LLP?
What is the significance of Robert Pelzer's appointment as Chairman of the Board at Sierra Oncology?
What are the key achievements of Robert Pelzer in his role at Sierra Oncology?
How does Robert Pelzer's background in life sciences investment benefit Sierra Oncology?
Robert Pelzer
Add to my network

Location

Canada